Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Annals of the Rheumatic Diseases|July 6, 2021
14-3-3 epsilon is an intracellular component of TNFR2 receptor complex and its activation protects against osteoarthritisWenyu Fu, Aubryanna Hettinghouse, Yujianan Chen, et al.The Journal of Experimental Medicine|January 30, 2013
Notch pathway activation targets AML-initiating cell homeostasis and differentiationCamille Lobry, Panagiotis Ntziachristos, Delphine Ndiaye-Lobry, et al.The Journal of Clinical Investigation|April 11, 2017
A proangiogenic signaling axis in myeloid cells promotes malignant progression of gliomaYujie Huang, Prajwal Rajappa, Wenhuo Hu, et al.Molecular Cancer Research : MCR|December 11, 2020
AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin SignalingSizhi Paul Gao, Amber J Kiliti, Kai Zhang, et al.The Journal of Pathology|March 7, 2019
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladderSumit Isharwal, Wenhuo Hu, Judy Sarungbam, et al.Science Translational Medicine|May 30, 2014
Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemiaStephen S Chung, Eunhee Kim, Jae H Park, et al.Cancer Discovery|January 9, 2025
Nonselective β-Adrenergic Receptor Inhibitors Impair Hematopoietic Regeneration in Mice and Humans after Hematopoietic Cell TransplantsJinsuke Nishino, Wenhuo Hu, Ashwin Kishtagari, et al.Cell Research|January 1, 2025
Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone lossWenyu Fu, Meng Chen, Kaidi Wang, et al.European Urology|October 7, 2018
Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant ChemotherapyEugene J Pietzak, Emily C Zabor, Aditya Bagrodia, et al.Nature|January 3, 2024
Na<sub>v</sub>1.7 as a chondrocyte regulator and therapeutic target for osteoarthritisWenyu Fu, Dmytro Vasylyev, Yufei Bi, et al.Pageof 4